Hansen Medical, Inc. (NASDAQ:HNSN) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 10.45%.
Hansen Medical, Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share decreased to $-0.26 in the quarter versus EPS of $-0.20 in the year-earlier quarter.
Revenue: Decreased 36.56% to $2.95 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Hansen Medical, Inc. reported adjusted EPS loss of $0.26 per share. By that measure, the company missed the mean analyst estimate of $-0.13. It missed the average revenue estimate of $5.76 million.
Quoting Management: “In a little over two quarters, the Company has gone from having just one installed clinical Magellan Robotic System to nine total clinical installations that are involved in treating patients and generating data, as of March 31,” said Bruce Barclay, Hansen Medical’s President and Chief Executive Officer. “I am encouraged by the breadth of clinical applications in the peripheral vasculature and the positive experiences that are being generated at these hospitals. These varied applications are demonstrating the real-world medical utility of Hansen Medical’s systems, and helping to drive further interest and adoption of our technology. Today, we are reporting another quarter of record procedures, marking the seventh consecutive quarter of procedure growth. This is further evidence of the value we believe physicians and hospitals can, and are, experiencing with our intravascular robotic systems. We are particularly encouraged by recent in vitro data and clinical experiences regarding the potential benefits of endovascular robotics in the treatment of carotid artery disease.”
Key Stats (on next page)…